
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points
EVR Research bought 100,000 shares of Ingevity in the fourth quarter. The quarter-end position value increased by $5.92 million due to the new position in NGVT.


















